Max Robotics — Global Service Robot Directory + US Certification

About

Bernard Klein was a pioneering researcher in clinical biochemistry and laboratory automation, whose work in the mid-1960s helped transform the way diagnostic enzyme and metabolite assays were performed in medical laboratories. Specializing in the automated determination of serum biochemical markers, Klein developed precise, reproducible procedures for measuring critical clinical analytes — including uric acid, alkaline phosphatase, acid phosphatase, lactate dehydrogenase, and glutamic oxaloacetic transaminase — using innovative platforms such as the AutoAnalyzer and the Robot Chemist. His most influential contribution, "The Automated Determination of Serum Uric Acid" (1966), garnered 42 citations and introduced an elegant enzymatic approach leveraging the cuprous-neocuproine complex, setting a methodological standard for automated clinical chemistry. His work on NAD-coupled enzyme assays (28 citations) further demonstrated his ingenuity in adapting biochemical reactions for high-throughput automation. Across seven notable publications, Klein consistently prioritized analytical precision and accuracy, addressing the growing demand for reliable, scalable diagnostic tools in clinical settings. Though his citation counts are modest by modern standards, his contributions represented foundational advances during a formative era of laboratory medicine automation.